ITGBL1 and colorectal carcinoma: Treatment of fibroblasts or stellate cells with ITGBL1-enriched EVs from CRC cells showed co-location of ITGBL1 with TNFAIP3 by Co-IP and immunofluorescence detection (Supplementary Fig. 12a–d).